These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3743174)

  • 1. Pulmonary hypertension, right ventricular failure, and vasodilator therapy. Making pathophysiologic sense.
    Davila F
    Chest; 1986 Sep; 90(3):467-8. PubMed ID: 3743174
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of heart failure in pulmonary arterial hypertension--the urgency of getting this right.
    Baliga RR; Young JB
    Heart Fail Clin; 2012 Jul; 8(3):xiii-xix. PubMed ID: 22748909
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful transition from intravenous to inhaled prostacyclin in a patient with pulmonary hypertension and right ventricular failure.
    Reddy MT; Patel H; Ventura HO
    Congest Heart Fail; 2008; 14(5):285-6. PubMed ID: 18983294
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraoperative management of pulmonary hypertension and associated right heart failure.
    Gordon C; Collard CD; Pan W
    Curr Opin Anaesthesiol; 2010 Feb; 23(1):49-56. PubMed ID: 19907315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levosimendan and pulmonary hypertension.
    Cavusoglu Y; Beyaztas A; Birdane A; Ata N
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):478-80. PubMed ID: 20516805
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic potential of sildenafil in patients with heart failure and reactive pulmonary hypertension.
    Dumitrescu D; Seck C; Möhle L; Erdmann E; Rosenkranz S
    Int J Cardiol; 2012 Jan; 154(2):205-6. PubMed ID: 22104986
    [No Abstract]   [Full Text] [Related]  

  • 7. Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.
    Gavazzi A; Ghio S; Scelsi L; Campana C; Klersy C; Serio A; Raineri C; Tavazzi L
    Am Heart J; 2003 Feb; 145(2):310-6. PubMed ID: 12595849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy with pentaerithrityltetranitrate (PETN). Established effectiveness, once again on trial].
    MMW Fortschr Med; 2011 Feb; 153(7):44-5. PubMed ID: 21648143
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary hypertension in heart failure.
    Guglin M; Khan H
    J Card Fail; 2010 Jun; 16(6):461-74. PubMed ID: 20610227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.
    Malhotra R; Dhakal BP; Eisman AS; Pappagianopoulos PP; Dress A; Weiner RB; Baggish AL; Semigran MJ; Lewis GD
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled iloprost plus levosimendan to decompensate right heart failure due to chronic thromboembolic pulmonary hypertension.
    Pitsiou G; Paspala A; Bagalas V; Boutou AK; Stanopoulos I
    Anaesth Intensive Care; 2013 Jul; 41(4):554-6. PubMed ID: 23808522
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of pulmonary hypertension with left heart disease: a concise review.
    Desai A; Desouza SA
    Vasc Health Risk Manag; 2017; 13():415-420. PubMed ID: 29158679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tezosentan and right ventricular failure in patients with pulmonary hypertension undergoing cardiac surgery: the TACTICS trial.
    Denault AY; Pearl RG; Michler RE; Rao V; Tsui SS; Seitelberger R; Cromie M; Lindberg E; D'Armini AM
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1212-7. PubMed ID: 23523254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasodilator therapy of cardiac failure (second of two parts).
    Cohn JN; Franciosa JA
    N Engl J Med; 1977 Aug; 297(5):254-8. PubMed ID: 327319
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversal of right-ventricular dysfunction in pulmonary arterial hypertension following sildenafil therapy.
    Romano S; Chung J; Farzaneh-Far A
    Eur Heart J; 2015 Aug; 36(30):2018. PubMed ID: 25713316
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhaled nitric oxide: therapeutic applications in cardiac surgery].
    Estanove S; Girard C; Bastien O; Piriou V; Lehot JJ
    Bull Acad Natl Med; 2000; 184(8):1715-26; discussion 1727-9. PubMed ID: 11471390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination pharmacotherapy for severe neonatal pulmonary hypertension.
    Filan PM; McDougall PN; Shekerdemian LS
    J Paediatr Child Health; 2006 Apr; 42(4):219-20. PubMed ID: 16630327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new horizon in the treatment of right ventricular failure and pulmonary hypertension associated with acute respiratory distress syndrome?
    Carlson RW; Emmans L
    Crit Care Med; 2006 Sep; 34(9):2487. PubMed ID: 16921319
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous fasudil improves in-hospital mortality of patients with right heart failure in severe pulmonary hypertension.
    Jiang R; Ai ZS; Jiang X; Yuan P; Liu D; Zhao QH; He J; Wang L; Gomberg-Maitland M; Jing ZC
    Hypertens Res; 2015 Aug; 38(8):539-44. PubMed ID: 25787034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levosimendan reverted severe pulmonary hypertension in one patient on waiting list for heart transplantation.
    Ammirati E; Musca F; Oliva F; Garascia A; Pacher V; Verde A; Cipriani M; Moreo A; Martinelli L; Frigerio M
    Int J Cardiol; 2013 Oct; 168(4):4518-9. PubMed ID: 23871623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.